C O M M U N I C A T I O N S
Scheme 3. Synthesis of Rubioncolin B via An Oxidation/Tautomerization/Diels-Alder Cycloaddition Cascadea
a Reagents and conditions: (a) allyltributyltin (1.1 equiv), BF3 ·Et2O (1.1 equiv), CH2Cl2, -78 °C, 90 min; H2O, 0 °C; TBSOTf (3 equiv), 2,6-lutidine (5 equiv),
CH2Cl2, 0 °C, 2 h, 35%; (b) K2OsO4 (0.01 equiv), NaIO4 (5 equiv), 1,4-dioxane, H2O, 23 °C, 12 h; NaClO2 (9 equiv), NaH2PO4 (7 equiv), 2-methyl-2-butene,
tert-butanol, 23 °C, 3 h, 45%; (c) i. (COCl)2 (1.5 equiv), DMF (1 drop), CH2Cl2, 2 h, 23 °C, then concentrate in vacuo; ii. 11 (1.2 equiv), Et3N (5 equiv), CH2Cl2,
23 °C, 12 h, 70%; (d) PhI(OAc)2 (1.1 equiv), TASF (2.1 equiv), CH3CN/H2O (20:1), 23 °C, 2 h, 60%; (e) BBr3 (1.1 equiv), CH2Cl2, -78 °C, 15 min, 95%. TASF
) tris(dimethylamino)sulfonium difluorotrimethylsilicate.
by expulsion of acetone to afford 9. Methylation, followed by lithiation
(f10) and addition to acetone afforded the tertiary alcohol 11.
Coupling partner 14 was synthesized in two straightforward steps
from the known naphthoquinone 1210 (Scheme 3; see Supporting
Information for details). The key esterification was accomplished by
conversion of 14 to the acid chloride 15, followed by exposure to 11
in the presence of triethylamine to provide hydroquinone bis-TBS ether
16 in 70% yield.
Acknowledgment. We thank Novartis, Roche Biosciences, and
the Lawrence Berkeley National Laboratory for supporting this work
and Pfizer Pharmaceuticals and the ACS Organic Division for a
predoctoral fellowship to J.-P.L. We also thank Dr. Jamin Krinsky
and Dr. Kathy Durkin for assistance with computations, and Dr. Fred
Hollander for X-ray structure analysis.
Supporting Information Available: Detailed synthetic and compu-
tational protocols. This material is available free of charge via the Internet
Initial attempts to elaborate 16 to the para-quinone were met with
difficulties as both acidic and basic conditions resulted in cleavage of
the benzylic ester. However, exposure of 16 to 2 equiv of TASF in
the presence of PhI(OAc)2 directly proVided rubioncolin B methyl ether
(22) in 60% isolated yield. Deprotection of 22 in the presence of BBr3
afforded synthetic rubioncolin B (1), whose structure was confirmed
by X-ray analysis (Scheme 1; see Supporting Information for details).
Presumably, this oxidation/tautomerization/Diels-Alder cascade
begins by TASF-mediated desilylation to provide a phenoxide 17.
Oxidation with PhI(OAc)2 then provides oxonium ion 18, which is
readily desilylated by a second equivalent of TASF, yielding quinone
19. As anticipated, 19 is in equilibrium with its ortho-quinone methide
tautomer 20. Endo transition state 21 was located at the B3LYP/6-
31G** level and is merely 15 kcal/mol higher in energy than the
ground-state conformation of 20. Therefore, once formed, 20 should
undergo a facile cycloaddition to afford rubioncolin B methyl ether
(22).
References
(1) For a comprehensive review, see: Van de Water, R. W.; Pettus, T. R. R.
Tetrahedron 2002, 58, 5367–5405. For recent examples in total synthesis,
see: Bulger, P. G.; Bagal, S. K.; Marquez, R Nat. Prod. Rep. 2008, 25,
254–297, and references therein.
(2) Peter, M. G. Angew. Chem., Int. Ed. Engl. 1989, 28, 555–570.
(3) Lumb, J. P.; Trauner, D. Org. Lett. 2005, 7, 5865–5868.
(4) A tautomerization/intermolecular cycloaddition has been reported by
Nicolaou, K. C.; Lim, Y. H.; Papageorgiou, C. D.; Piper, J. L. Angew.
Chem., Int. Ed. 2005, 44, 7917–7921.
(5) Itokawa, H.; Ibraheim, Z. Z.; Qiao, Y. F.; Takeya, K. Chem. Pharm. Bull.
1993, 41, 1869–1872, and references therein.
(6) Singh, R.; Geetanjali; Chauhan, S. M. S. Chem. BiodiVersity 2004, 1, 1241–
1264.
(7) For the biomimetic synthesis of another member in this family, see: Lumb,
J. P.; Trauner, D. J. Am. Chem. Soc. 2005, 127, 2870–2871.
(8) Jaguar, version 6.5; Schro¨dinger, LLC: New York, NY, 2006. See
Supporting Information for details.
(9) (a) Ciganek, E. J. Am. Chem. Soc. 1981, 103, 6261–6262, and references
therein. (b) An intramolecular Diels–Alder addition to a benzofuran has
been used in a total synthesis of morphine. Gilbert Stork, private
communication. (c) Chen, C. H.; Rao, P. D.; Liao, C. C. J. Am. Chem.
Soc. 1998, 120, 13254–13255. (d) Noland, W. E.; Kedrowski, B. L. J. Org.
Chem. 1999, 64, 596–603.
(10) For a synthesis of quinone 12, see: Barker, D.; Brimble, M. A.; Do, P.;
Turner, P. Tetrahedron 2003, 59, 2441–2449. For a similar Sakurai-type
allylation, see: Uno, H. J. Org. Chem. 1986, 51, 350–358.
We believe that our synthesis sheds light onto the biosynthetic origin
of rubioncolin B. The spontaneous conversion of 19 into 22 provides
further evidence that ortho-quinone methides can be formed in Nature
via facile tautomerization of para-quinone precursors. This process
does not necessitate enzymatic assistance and, as a result, provides a
reasonable explanation for the isolation of 1 as a racemate.
JA803498R
9
J. AM. CHEM. SOC. VOL. 130, NO. 29, 2008 9231